RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
暂无分享,去创建一个
B. Portz | Lin Guo | J. Shorter | J. Brodsky | U. Pandey | J. Kofler | A. Thathiah | Christopher J. Donnelly | J. Mauna | A. Gleixner | Katie E. Copley | J. Mann | Edward Gomes | Patrick G. Needham | Noah J. Pyles | Christopher B. Calder | Bryan T. Hurtle | M. DeChellis-Marks | Zachary P. Wills
[1] A. Gitler,et al. Pour Some Sugar on TDP(-43). , 2018, Molecular cell.
[2] R. Kalb,et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. , 2018, Molecular cell.
[3] C. van Broeckhoven,et al. ALS Genes in the Genomic Era and their Implications for FTD. , 2018, Trends in genetics : TIG.
[4] P. Tomançak,et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins , 2018, Science.
[5] Seung Joong Kim,et al. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites , 2018, Cell.
[6] Julie C. Sung,et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains , 2018, Cell.
[7] E. L. Guenther,et al. Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2 , 2018, Nature Structural & Molecular Biology.
[8] E. Feldman,et al. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization , 2018, bioRxiv.
[9] Nicolas L. Fawzi,et al. A single N‐terminal phosphomimic disrupts TDP‐43 polymerization, phase separation, and RNA splicing , 2018, The EMBO journal.
[10] C. Brangwynne,et al. Liquid phase condensation in cell physiology and disease , 2017, Science.
[11] F. Allain,et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation , 2017, Nature Communications.
[12] D. Laurents,et al. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions , 2017, The Journal of Biological Chemistry.
[13] J. Shorter,et al. RNA-binding proteins with prion-like domains in health and disease. , 2017, The Biochemical journal.
[14] David A. Knowles,et al. Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice , 2017, Nature.
[15] Jeffrey J. Nirschl,et al. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons , 2017, Proceedings of the National Academy of Sciences.
[16] A. Chakrabartty,et al. Phase to Phase with TDP-43. , 2017, Biochemistry.
[17] Jared E. Toettcher,et al. Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets , 2017, Cell.
[18] E. Buratti,et al. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins , 2016, Scientific Reports.
[19] Nicolas L. Fawzi,et al. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. , 2016, Structure.
[20] R. Rohatgi,et al. In Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes. , 2016, Cell reports.
[21] P. van Damme,et al. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD , 2016, Acta Neuropathologica.
[22] M. Kinjo,et al. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity , 2016, Scientific Reports.
[23] Peter Tompa,et al. Polymer physics of intracellular phase transitions , 2015, Nature Physics.
[24] Erin M. Langdon,et al. RNA Controls PolyQ Protein Phase Transitions. , 2015, Molecular cell.
[25] A. Kanagaraj,et al. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization , 2015, Cell.
[26] Sean J. Miller,et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport , 2015, Nature.
[27] Bruce L. Miller,et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport , 2015, Nature.
[28] J. Rothstein,et al. Rodent Models of Amyotrophic Lateral Sclerosis , 2015, Current protocols in pharmacology.
[29] C. Brangwynne,et al. The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics , 2015, Proceedings of the National Academy of Sciences.
[30] Timothy D. Craggs,et al. Phase Transition of a Disordered Nuage Protein Generates Environmentally Responsive Membraneless Organelles , 2015, Molecular cell.
[31] C. Shaw,et al. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets , 2015, Neurotherapeutics.
[32] C. Yip,et al. Binding of TDP-43 to the 3'UTR of its cognate mRNA enhances its solubility. , 2014, Biochemistry.
[33] Justin D. Vrana,et al. An optimized optogenetic clustering tool for probing protein interaction and function , 2014, Nature Communications.
[34] Chunxing Yang,et al. TDP-43—The key to understanding amyotrophic lateral sclerosis , 2014, Rare diseases.
[35] J. Trojanowski,et al. Therapeutic modulation of eIF2α-phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models , 2013, Nature Genetics.
[36] S. Lorenzl,et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations , 2013, Acta Neuropathologica.
[37] D. Cleveland,et al. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.
[38] C. van Broeckhoven,et al. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders , 2013, Human molecular genetics.
[39] M. Myers,et al. Characterizing TDP-43 interaction with its RNA targets , 2013, Nucleic acids research.
[40] Rebecca B. Smith,et al. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. , 2013, Human molecular genetics.
[41] Gene W. Yeo,et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 , 2013, Proceedings of the National Academy of Sciences.
[42] B. Wolozin,et al. TDP-43: A new player on the AD field? , 2012, Experimental Neurology.
[43] Tai-Huang Huang,et al. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. , 2012, Biochemical and biophysical research communications.
[44] C. Haass,et al. Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)* , 2012, The Journal of Biological Chemistry.
[45] T. Hortobágyi,et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.
[46] R. Baloh. TDP‐43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration , 2011, The FEBS journal.
[47] J. Kril,et al. Cytoplasmic Accumulation and Aggregation of TDP-43 upon Proteasome Inhibition in Cultured Neurons , 2011, PloS one.
[48] Jernej Ule,et al. TDP‐43 regulates its mRNA levels through a negative feedback loop , 2011, The EMBO journal.
[49] M. Ehlers,et al. Rapid blue light induction of protein interactions in living cells , 2010, Nature Methods.
[50] Brandon E Gavett,et al. TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy , 2010, Journal of neuropathology and experimental neurology.
[51] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[52] E. Buratti,et al. TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.
[53] A. Hyman,et al. Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation , 2009, Science.
[54] L. Petrucelli,et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.
[55] P. Kuo,et al. Structural insights into TDP-43 in nucleic-acid binding and domain interactions , 2009, Nucleic acids research.
[56] P. Anderson,et al. Stress granules: the Tao of RNA triage. , 2008, Trends in biochemical sciences.
[57] Ed Hurt,et al. Exporting RNA from the nucleus to the cytoplasm , 2007, Nature Reviews Molecular Cell Biology.
[58] F. Edwards,et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines , 2007, BMC Neuroscience.
[59] M. Rexach,et al. Natively Unfolded Nucleoporins Gate Protein Diffusion across the Nuclear Pore Complex , 2007, Cell.
[60] Murray Grossman,et al. TDP-43-Positive White Matter Pathology in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions , 2007, Journal of neuropathology and experimental neurology.
[61] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[62] D. Handy,et al. The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels* , 2006, The Journal of Biological Chemistry.
[63] Francisco E. Baralle,et al. Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9* , 2001, The Journal of Biological Chemistry.
[64] J. Williamson. Induced fit in RNA–protein recognition , 2000, Nature Structural Biology.
[65] J. Buchan,et al. Stress Granules and ALS: A Case of Causation or Correlation? , 2018, Advances in neurobiology.